Business Description
HCA Healthcare Inc
NAICS : 622110
SIC : 8062
ISIN : BRH1CABDR002
Share Class Description:
BSP:H1CA34: BRDRCompare
Compare
Traded in other countries / regions
HCA.USA0J1R.UKH1CA34.BrazilHCA.Mexico2BH.Germany1HCA.Italy IPO Date
2019-12-16Description
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of June 2024, the firm owned and operated 188 hospitals, 123 freestanding outpatient surgery centers, and a broad network of physician offices, urgent-care clinics, and freestanding emergency rooms across 20 states and a small foothold in England.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.06 | |||||
| Equity-to-Asset | -0.04 | |||||
| Debt-to-Equity | -20.57 | |||||
| Debt-to-EBITDA | 3.21 | |||||
| Interest Coverage | 5.19 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 2.61 | |||||
| Beneish M-Score | -2.81 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 16.2 | |||||
| 3-Year EBITDA Growth Rate | 17.6 | |||||
| 3-Year EPS without NRI Growth Rate | 17.8 | |||||
| 3-Year FCF Growth Rate | -3.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 12.8 | |||||
| Future 3-5Y Total Revenue Growth Rate | 6.58 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 33.9 | |||||
| 9-Day RSI | 30.76 | |||||
| 14-Day RSI | 32.38 | |||||
| 6-1 Month Momentum % | 25.85 | |||||
| 12-1 Month Momentum % | 67.31 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.12 | |||||
| Quick Ratio | 1 | |||||
| Cash Ratio | 0.19 | |||||
| Days Inventory | 65.97 | |||||
| Days Sales Outstanding | 51.73 | |||||
| Days Payable | 147.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.5 | |||||
| Dividend Payout Ratio | 0.08 | |||||
| 3-Year Dividend Growth Rate | 77.4 | |||||
| Forward Dividend Yield % | 0.55 | |||||
| 5-Year Yield-on-Cost % | 1.05 | |||||
| 3-Year Average Share Buyback Ratio | 7.9 | |||||
| Shareholder Yield % | 4.38 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 84.85 | |||||
| Operating Margin % | 15.09 | |||||
| Net Margin % | 8.52 | |||||
| FCF Margin % | 8.49 | |||||
| ROE % | Neg. Equity | |||||
| ROA % | 10.42 | |||||
| ROIC % | 17.86 | |||||
| ROC (Joel Greenblatt) % | 31.42 | |||||
| ROCE % | 24.77 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 14.81 | |||||
| Forward PE Ratio | 13.7 | |||||
| PE Ratio without NRI | 15.23 | |||||
| Shiller PE Ratio | 22.58 | |||||
| Price-to-Owner-Earnings | 14.69 | |||||
| PEG Ratio | 1.07 | |||||
| PS Ratio | 1.26 | |||||
| Price-to-Free-Cash-Flow | 14.87 | |||||
| Price-to-Operating-Cash-Flow | 8.23 | |||||
| EV-to-EBIT | 11.32 | |||||
| EV-to-Forward-EBIT | 11.19 | |||||
| EV-to-EBITDA | 8.7 | |||||
| EV-to-Forward-EBITDA | 8.54 | |||||
| EV-to-Revenue | 1.75 | |||||
| EV-to-Forward-Revenue | 1.67 | |||||
| EV-to-FCF | 21.31 | |||||
| Price-to-Projected-FCF | 1.24 | |||||
| Price-to-DCF (Earnings Based) | 0.61 | |||||
| Price-to-DCF (FCF Based) | 0.65 | |||||
| Price-to-Median-PS-Value | 1.27 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.93 | |||||
| Earnings Yield (Greenblatt) % | 8.83 | |||||
| FCF Yield % | 7.13 | |||||
| Forward Rate of Return (Yacktman) % | 21.62 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HCA Healthcare Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil R$) | 362,179.161 | ||
| EPS (TTM) (R$) | 5.77 | ||
| Beta | 0.56 | ||
| Volatility % | 21.12 | ||
| 14-Day RSI | 32.38 | ||
| 14-Day ATR (R$) | 1.705444 | ||
| 20-Day SMA (R$) | 100.246 | ||
| 12-1 Month Momentum % | 67.31 | ||
| 52-Week Range (R$) | 60.06 - 118.68 | ||
| Shares Outstanding (Mil) | 5,065.94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
HCA Healthcare Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
HCA Healthcare Inc Stock Events
| Event | Date | Price(R$) | ||
|---|---|---|---|---|
| No Event Data | ||||
HCA Healthcare Inc Frequently Asked Questions
What is HCA Healthcare Inc(BSP:H1CA34)'s stock price today?
The current price of BSP:H1CA34 is R$95.75. The 52 week high of BSP:H1CA34 is R$118.68 and 52 week low is R$60.06.
When is next earnings date of HCA Healthcare Inc(BSP:H1CA34)?
The next earnings date of HCA Healthcare Inc(BSP:H1CA34) is 2025-01-30 Est..
Does HCA Healthcare Inc(BSP:H1CA34) pay dividends? If so, how much?
The Dividend Yield %  of HCA Healthcare Inc(BSP:H1CA34) is 0.5% (As of Today), Highest Dividend Payout Ratio of HCA Healthcare Inc(BSP:H1CA34) was 0.15. The lowest was 0.04. And the median was 0.13. The  Forward Dividend Yield % of HCA Healthcare Inc(BSP:H1CA34) is 0.55%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers